Photon Capital Advisors Ltd

As of October 20, 2025, Photon Capital is considered very expensive and overvalued, with a PE ratio of -30.77 and unfavorable comparisons to peers like Bajaj Finance and Life Insurance, despite recent stock performance.

As of October 17, 2025, Photon Capital is considered overvalued with a negative PE ratio of -27.79 and an EV to EBITDA ratio of -12.49, indicating significant concerns about profitability despite recent stock performance.

As of October 17, 2025, Photon Capital is considered overvalued with a PE ratio of -27.79 and significant financial distress, especially when compared to peers like Bajaj Finance and Life Insurance, despite a recent short-term outperformance against the Sensex.

As of October 17, 2025, Photon Capital is considered overvalued with a PE ratio of -27.79 and negative profitability metrics, making it less favorable compared to peers like Bajaj Finance and Life Insurance, despite a year-to-date stock performance of 14.29% versus the Sensex's 7.44%.

Photon Capital has experienced significant fluctuations in its financial performance, with net sales increasing to INR 0.36 crore in March 2022 before declining to INR 0.24 crore by March 2025, alongside a notable drop in profitability and cash flow, culminating in losses by March 2025. Total assets and liabilities decreased from INR 6.96 crore in March 2022 to INR 6.44 crore in March 2025.

As of October 10, 2025, Photon Capital is considered overvalued with a valuation grade of expensive, reflected by a negative PE ratio of -13.62, an EV to EBITDA of -9.99, and a ROE of -26.41%, significantly underperforming compared to peers and the Sensex.

As of October 10, 2025, Photon Capital is considered overvalued with a valuation grade of expensive, reflected by a negative PE Ratio of -13.62 and poor performance compared to peers and the Sensex.

As of October 10, 2025, Photon Capital is considered overvalued with a negative PE ratio of -13.62, an EV to EBIT of -9.99, and a ROE of -26.41%, significantly underperforming compared to peers and the Sensex.

The next results date for Photon Capital is 17 October 2025.

As of September 19, 2025, Photon Capital is considered overvalued and risky due to its negative PE ratio of -15.71, negative EV to EBITDA of -12.04, and ROE of -24.00%, despite a strong YTD return of 11.40%.

As of September 19, 2025, Photon Capital is considered overvalued and risky, with poor financial ratios including a PE ratio of -15.71 and an ROE of -24.00%, despite a strong annual return of 14.70%.

As of September 19, 2025, Photon Capital is considered overvalued and risky due to its negative PE ratio of -15.71 and poor operational efficiency, especially when compared to peers like Bajaj Finance and Life Insurance, despite a year-to-date return of 11.40%.

As of September 12, 2025, Photon Capital is considered overvalued with a PE ratio of -16.54 and an EV to EBITDA of -12.87, indicating significant financial challenges compared to peers like Bajaj Finance and Life Insurance, despite a recent stock return of 35.73%.

As of September 12, 2025, Photon Capital is considered overvalued with a negative PE ratio of -16.54 and significant financial distress, making it an unfavorable investment compared to peers like Bajaj Finance and Life Insurance.

As of September 12, 2025, Photon Capital is considered overvalued with a PE ratio of -16.54 and an EV to EBITDA of -12.87, making it a less favorable investment compared to peers like Bajaj Finance and Life Insurance, despite a strong year-to-date return of 17.25%.

As of September 10, 2025, Photon Capital is considered overvalued with a PE ratio of -17.41 and an EV to EBITDA ratio of -13.74, despite a year-to-date stock performance of 23.42%, contrasting sharply with peers like Bajaj Finance and Life Insurance.

As of September 4, 2025, Photon Capital is considered overvalued with a PE Ratio of -17.41 and negative returns on equity and capital, despite a recent 1Y return of 48.39%, indicating significant financial challenges compared to its peers.

As of September 3, 2025, Photon Capital is considered overvalued with a risky valuation grade, reflected by a PE ratio of -16.65, an EV to EBITDA of -12.98, and a ROE of -24.00%, especially when compared to peers like Bajaj Finance and Life Insurance, despite a strong year-to-date stock return of 18.05%.

As of August 29, 2025, Photon Capital is considered overvalued with a PE ratio of -15.89 and an EV to EBITDA ratio of -12.22, indicating negative earnings, and its valuation is unfavorable compared to peers like Bajaj Finance and Bajaj Finserv, despite a strong return of 35.48% over the past year.